We sat down with drug development industry researcher Valerie Bowling, a veteran conference director who covers the clinical trials market, to discuss her views on R&D trends and challenges and why she launched DPharm, a disruptive thinking conference for clinical trials (held this year in Boston, September 25-26).
Topics: Conferences, Disruptive Innovation, clinical research